Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 106, n° 3
pages 155-161 (mars 2013)
Doi : 10.1016/j.acvd.2012.12.007
Received : 24 October 2012 ;  accepted : 18 December 2012
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors
Impact de lésions coronaires multitronculaires sur la perfusion myocardique et sur la survie chez des patients d’une revascularisation coronaire percutanée sous anti GPIIbIIIa
 

Figure 1




Figure 1 : 

Impact of vessel disease on postprocedural TIMI 3 flow, complete ST-segment resolution (STSR), myocardial blush grade (MBG) 3 and distal embolization.


Figure 2




Figure 2 : 

Kaplan–Meier survival curves showing significant impact of vessel disease on survival.


Figure 3




Figure 3 : 

Kaplan–Meier survival curves showing the outcome of early and late administration of GP IIb/IIIa inhibitors according to vessel disease. MVD=multivessel disease; SVD=single vessel disease.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline